North America Cannabis Market: Focus On Application, Derivative, And Region - Estimation & Forecast, 2015-2020

  • ID: 3396391
  • Report
  • Region: America, North America, United States
  • 249 pages
  • BIS Research
1 of 6
North American Cannabis Market Value to Grow Over $20.7 Billion by 2020

FEATURED COMPANIES

  • 22nd Century Group, Inc.
  • Cannabis Sativa Inc.
  • Dave
  • Grassp
  • Leafly
  • Medical Marijuana Inc.
  • MORE
Cannabis is the most widely used of all psychoactive drugs in the market due to its derivative products and their uses, its applications and wide acceptance. Owing to the medicinal and industrial uses of the cannabis plant, cannabis market is growing rapidly. Factors like multifaceted applications of cannabis, expansion of licensing strategies, and automated irrigation system among others are driving this market towards growth. This market is also tackling some issues like volatile regulatory framework, absence of market leaders, perception towards marijuana, and environmental hazards among others.

The North America Cannabis market is poised to grow from $ 3.46 billion in 2014 to $20.67 billion in 2020 at an estimated CAGR of 29.80% from 2015 to 2020. While medical marijuana has already been legalized across half of the states in the U.S., including California, Washington, Colorado, and New York among others, legal use of recreational marijuana closely, yet rapidly follows. The market is expected to be driven by a host of driving factors such as adoption of Information Technology and Automation, Application of Hydroponic, and Increasing popularity of e-cigarettes with cannabis oil among others. However, the highly volatile regulatory framework, marijuana stigma, and the highly fragmented supply chain will continue to challenge the market through the forecast period.

Owing to the fragmented supply chain and the presence of black market and perception issues, the cannabis market in North America has been estimated and forecasted strictly for the legal states, both for marijuana and hemp. The following pointers will encompass the scope of the research study and will lend a better understanding to the reader.

- The total cannabis market is inclusive of the two primary derivatives namely-marijuana and Industrial Hemp
- The market estimation for marijuana includes revenue from the legalized and active markets and Canada, where only medical marijuana is legalized
- Certain states have legalized medical and recreational marijuana after 2013, however, there markets are not yet active and therefore, their market shares are not included in the total market size for the benchmark year (2014)
- The report includes revenue for the marijuana market for all the active states having market share of above 0.5%. Rest of the state’s revenue are clubbed as others
- Through the forecast period, the ‘other’ states segment will also include the revenue from further states that are anticipated to legalize medical marijuana
- The market size by application has been further segmented as applications of marijuana and industrial hemp for better clarity
- The report includes the estimates of different entities of the cannabis ecosystem
- The report also includes the optimistic revenue estimate for the benchmark year only for the U.S
- Tax revenue estimate in case when marijuana is legalized across all the states in the U.S. has also been included

The size of the market for cannabis implies that market participants are more varied. Thus, the company profile section has been broken down into different types of market participants: producers, information technology, funding & finance, equipment & infrastructure, research & development, advisory services & education, branding, sales & marketing, and retail & dispensary.

Key questions answered in the report:
- What are the commercial derivative products of cannabis plant?
- What are the different application areas of cannabis plant and its derivatives?
- Which is the most sought-after distribution channel in the market?
- What are the prominent consortiums, compliances and regulatory bodies in this market?
- What are the different factors driving the market in the forecast period?
- What are the factors challenging the growth of Cannabis Market in North America?
- Who are the different participants in the North American Cannabis Market?
- What new strategies adopted by existing market players to make a mark in the industry?
- Which state will lead the Cannabis Market by the end of the forecast period?
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • 22nd Century Group, Inc.
  • Cannabis Sativa Inc.
  • Dave
  • Grassp
  • Leafly
  • Medical Marijuana Inc.
  • MORE
1 Research Methodology, Scope And Coverage
1.1 Scope Of The Study
1.2 Research Methodology
1.2.1 Overall Market Estimation And Forecast
1.2.2 Research Methodology
1.3 Report Description

2 Executive Summary

3 Introduction To North American Cannabis Market
3.1 Cannabis Market Evolution And Trend
3.2 The Cannabis Ecosystem In North America: Estimate And Forecast
3.3 The Optimistic Estimate For The U.S. Marijuana Market
3.4 Tax Revenue Estimation For The U.S. Marijuana Market

4 Key Strategies And Development In The North American Cannabis Market (2013-2015)
4.1 Introduction
4.2 Mergers And Acquisitions
4.3 Partnership, Collaboration & Joint Ventures
4.4 Product Launch
4.5 Business Expansion
4.6 Product Testing
4.7 Others

5 Market Dynamics
5.1 Introduction
5.2 Market Drivers
5.2.1 Automation Transforming The Cannabis Industry
5.2.1.1 Collaboration Of The Vending And Cannabis Industry
5.2.1.2 Automated Irrigation Systems And Fertilization
5.2.2 Increasing Adoption Of Information Technology In The Cannabis Industry
5.2.3 Rapid Adoption Of Cannabis For Medical Purposes
5.2.4 Multi-Faceted Applications Of Cannabis Derivatives
5.2.5 The Profitable Integration Of The Hydroponics And Cannabis Industry
5.2.6 The Combined Effect Of Vaper's Preference For Cannabis Oil And Increasing Adoption Of E-Cigarette
5.3 Market Challenges
5.3.1 Highly Volatile Regulatory Framework
5.3.2 Absence Of Market Leaders And Standards
5.3.3 The Issues Of Perception (Reputation Of Marijuana)/Marijuana Stigma
5.3.4 Federal Level Challenges
5.3.4.1 Lack Of Availability Of Bank Loans To Set Up Operations Due To Federal Banking Prerequisites
5.3.4.2 Federal Ban On Growing Industrial Hemp Forcing The Market Players To Import Raw Hemp
5.3.5 Highly Fragmented Supply Chain
5.3.6 Environmental Hazards

6 North America Cannabis Industry Analysis
6.1 Porter’s Five Forces Analysis
6.1.1 Threat Of New Entrants
6.1.1.1 Entry Barriers (Government Policy And Capital Requirements)
6.1.1.2 Access To Distribution Channels
6.1.1.3 Economies Of Scale
6.1.1.4 Product Differentiation
6.1.2 Bargaining Power Of Buyers
6.1.2.1 Concentration Of Buyers
6.1.2.2 Importance Of Volume To Buyers
6.1.2.3 Threat Of Backward Integration
6.1.2.4 Buyer’s Information About Supplier’s Product
6.1.2.5 The Existence Of Black Market
6.1.2.6 Switching Cost
6.1.2.7 Legal And Regulatory Framework
6.1.2.8 Presence Of Substitutes
6.1.3 Bargaining Power Of Suppliers
6.1.3.1 Supplier Concentration
6.1.3.2 Threat Of Forward Integration
6.1.3.3 Product Differentiation
6.1.3.4 Switching Cost
6.1.4 Threat From Substitutes
6.1.4.1 Buyer’s Propensity Towards Substitute
6.1.4.2 Consumer’s Switching Cost
6.1.5 Intensity Of Competitive Rivalry
6.1.5.1 Customer’s Loyalty Towards Brand
6.1.5.2 Intermittent Over Capacity
6.1.5.3 Product Differentiation
6.1.5.4 Industry Concentration
6.1.5.5 Entry Barriers
6.1.5.6 Exit Barriers
6.2 Value Chain Analysis
6.2.1 Introduction
6.2.2 Cannabis Growers/Producers
6.2.3 Pharmaceutical Companies
6.2.3.1 Research Facilities
6.2.4 Processing Industries
6.2.5 Packaging Industries
6.2.6 Dispensaries
6.2.6.1 Retail
6.2.6.2 Medical
6.2.6.3 Retail Outlets

7 Regulatory & Legal Framework, Consortiums And Compliances
7.1 Introduction
7.2 Regulatory Bodies
7.2.1 Health Canada- Marijuana For Medical Purposes Regulations (MMPR)
7.2.2 Council On Responsible Cannabis Regulation (CRCR)
7.2.3 National Organization For The Reform Of Marijuana Laws (NORML)
7.3 Legal Framework
7.3.1 Federal Marijuana Law- Controlled Substance Act (CSA)
7.3.2 Marijuana Control Act 201
7.3.3 Hemp Farming Act 201
7.4 Compliances
7.4.1 Massachusetts Marijuana Compliance
7.4.2 Marijuana Enforcement Tracking Reporting Compliance (METRC)
7.5 Consortiums
7.5.1 American Herbal Products Association (AHPA)
7.5.2 Association Of Responsible Cannabis Public Companies (ARCPC)
7.5.3 Hemp Industries Association (HIA)
7.5.4 Drug Policy Alliance
7.5.5 International Association For Cannabinoid Medicine (IACM)
7.5.6 National Cannabis Industry Association (NCIA)
7.5.7 Canadian Medical Cannabis Industry Association (CMCIA)
7.5.8 California Cannabis Industry Association (CCIA)
7.5.9 Illinois Cannabis Industry Association
7.5.10 North American Industrial Hemp Council Inc. (NAIHC)
7.5.11 Canadian Hemp Trade Alliance (CHTA)
7.5.12 Kentucky Hemp Industries Association (KYHIA)

8 Market Sizing – Estimation, Analysis & Forecast By Derivative
8.1 Introduction
8.1.1 Market Statistics
8.1.2 Marijuana/Flowers
8.1.2.1 Market Statistics
8.1.2.2 Key Players
8.1.3 Industrial Hemp
8.1.3.1 Market Statistics
8.1.3.2 Key Players
8.1.4 Other Concentrates/Products
8.1.4.1 Kief
8.1.4.2 Hash
8.1.4.3 Hash Oil
8.1.4.4 Tinctures
8.1.4.5 Infusions

9 Market Sizing- Estimation, Analysis & Forecast By Application
9.1 Introduction
9.1.1 Market Statistics
9.2 Applications Of Marijuana
9.2.1 Medicinal Applications
9.2.1.1 Market Statistics
9.2.1.2 Key Players
9.2.2 Recreational Application Of Marijuana
9.2.2.1 Market Statistics
9.3 Applications Of Industrial Hemp
9.3.1 Food And Baby Care
9.3.1.1 Market Statistics
9.3.2 Clothing & Textile
9.3.2.1 Market Statistics
9.3.3 Other Hemp Products
9.3.3.1 Market Statistics

10 Market Sizing Analysis & Forecast, By Market Demand
10.1 Introduction
10.1.1 Market Statistics
10.2 The U.S.
10.2.1 Market Statistics
10.2.2 California
10.2.3 Colorado
10.2.4 Washington
10.2.5 Arizona
10.2.6 Michigan
10.2.7 Oregon
10.2.8 Others
10.2.9 Legal & Regulatory Framework
10.2.9.1 Marijuana
10.2.9.2 Industrial Hemp
10.2.10 Key Market Players
10.3 Canada
10.3.1 Market Statistics
10.3.2 Key Market Players

11 Key Market Players Profile
11.1 Growers
11.1.1 Canadian Cannabis Corporation
11.1.1.1 Company Overview
11.1.1.2 Financials
11.1.1.2.1 Overall Financials
11.1.1.2.2 Financial Summary
11.1.1.3 Key Developments
11.1.2 Plandai Biotechnology
11.1.2.1 Company Overview
11.1.2.2 Financials
11.1.2.2.1 Overall Financials
11.1.2.2.2 Financial Summary
11.1.2.3 Key Developments
11.1.3 Tweed Marijuana Inc.
11.1.3.1 Company Overview
11.1.3.2 Financials
11.1.3.2.1 Overall Financials
11.1.3.2.2 Financial Summary
11.1.3.3 Key Developments
11.1.4 Affinor Growers
11.1.4.1 Company Overview
11.1.4.2 Financials
11.1.4.2.1 Overall Financials
11.1.4.2.2 Financial Summary
11.1.4.3 Key Developments
11.2 Producers
11.2.1 Cannabis Sativa Inc.
11.2.1.1 Company Overview
11.2.1.2 Financials
11.2.1.2.1 Overall Financials
11.2.1.2.2 Financial Summary
11.2.1.3 Key Developments
11.2.2 Cannavest
11.2.2.1 Company Overview
11.2.2.2 Financials
11.2.2.2.1 Overall Financials
11.2.2.2.2 Financial Summary
11.2.2.3 Key Developments
11.2.3 Canna Brands Inc.
11.2.3.1 Company Overview
11.2.3.2 Financial Summary
11.2.3.3 Key Developments
11.2.4 Omnicanna Health Solutions
11.2.4.1 Company Overview
11.2.4.2 Financial Summary
11.2.4.3 Key Developments
11.2.5 Privateer Holdings, Inc.
11.2.5.1 Company Overview
11.2.5.2 Key Developments
11.3 Pharmaceutical & Research Companies
11.3.1 Arena Pharmaceuticals, Inc.
11.3.1.1 Company Overview
11.3.1.2 Financials
11.3.1.2.1 Overall Financials
11.3.1.2.2 Financial Summary
11.3.1.3 Key Developments
11.3.2 Cannabics Pharmaceuticals Inc.
11.3.2.1 Company Overview
11.3.2.2 Financial Summary
11.3.2.3 Key Developments
11.3.3 Cannabis Science, Inc.
11.3.3.1 Company Overview
11.3.3.2 Financials
11.3.3.2.1 Overall Financials
11.3.3.2.2 Financial Summary
11.3.3.3 Key Developments
11.3.4 Gw Pharmaceuticals
11.3.4.1 Company Overview
11.3.4.2 Financials
11.3.4.2.1 Overall Financials
11.3.4.2.2 Revenue By Segment
11.3.4.2.3 Revenue By Region
11.3.4.2.4 Financial Summary
11.3.4.3 Key Developments
11.3.5 Hemp, Inc.
11.3.5.1 Company Overview
11.3.5.2 Financials
11.3.5.2.1 Overall Financials
11.3.5.2.2 Financial Summary
11.3.5.3 Key Developments
11.3.6 Insys Therapeutics
11.3.6.1 Company Overview
11.3.6.2 Financials
11.3.6.2.1 Overall Financials
11.3.6.2.2 Revenue By Segment
11.3.6.2.3 Financial Summary
11.3.6.3 Key Developments
11.3.7 Medical Marijuana Inc.
11.3.7.1 Company Overview
11.3.7.2 Financials
11.3.7.2.1 Overall Financials
11.3.7.2.2 Financial Summary
11.3.7.3 Key Developments
11.3.8 22nd Century Group, Inc.
11.3.8.1 Company Overview
11.3.8.2 Financials
11.3.8.2.1 Overall Financials
11.3.8.2.2 Financial Summary
11.3.8.3 Key Developments
11.3.9 Otsuka Pharmaceutical Co. Ltd
11.3.9.1 Company Overview
11.3.9.2 Financials
11.3.9.2.1 Overall Financials
11.3.9.2.2 Revenue By Segment
11.3.9.2.3 Revenue By Region
11.3.9.2.4 Financial Summary
11.3.9.3 Key Developments
11.3.10 Sanofi Pharmaceuticals
11.3.10.1 Company Overview
11.3.10.2 Financials
11.3.10.2.1 Overall Financials
11.3.10.2.2 Financial Summary
11.4 Information Technology
11.4.1 Agrisoft Development Group
11.4.1.1 Company Overview
11.4.1.2 Key Developments
11.4.2 Endexx Corporation
11.4.2.1 Company Overview
11.4.2.2 Financials
11.4.2.2.1 Overall Financials
11.4.2.3 Key Developments
11.4.3 Green Technology Solutions Inc. (Gtso)
11.4.3.1 Company Overview
11.4.3.2 Financials
11.4.3.2.1 Overall Financials
11.4.3.2.2 Financial Summary
11.4.3.3 Key Developments
11.4.4 Quantum 9
11.4.4.1 Company Overview
11.4.4.2 Financials
11.4.4.3 Key Developments
11.5 Equipment & Infrastructure
11.5.1 Advanced Cannabis Solutions
11.5.1.1 Company Overview
11.5.1.2 Financials
11.5.1.2.1 Overall Financials
11.5.1.2.2 Revenue By Segment
11.5.1.2.3 Financial Summary
11.5.1.3 Key Developments
11.5.2 Medbox, Inc.
11.5.2.1 Company Overview
11.5.2.2 Financials
11.5.2.2.1 Overall Financials
11.5.2.2.2 Financial Summary
11.5.2.3 Key Developments
11.5.3 Surna, Inc.
11.5.3.1 Company Overview
11.5.3.2 Financials
11.5.3.2.1 Overall Financials
11.5.3.2.2 Financial Summary
11.5.3.3 Key Developments
11.6 Advisory Services And Education
11.6.1 Canna Grow Holdings
11.6.1.1 Company Overview
11.6.1.2 Financials
11.6.1.2.1 Overall Financials
11.6.1.2.2 Financial Summary
11.6.1.3 Key Development
11.7 Others
11.7.1 Abattis Bioceuticals Corporation
11.7.1.1 Company Overview
11.7.1.2 Financials
11.7.1.2.1 Overall Financials
11.7.1.2.2 Financial Summary
11.7.1.3 Key Developments
11.7.2 Cannabis Therapy Corporation
11.7.2.1 Company Overview
11.7.2.2 Financials
11.7.2.2.1 Overall Financials
11.7.2.2.2 Financial Summary
11.7.2.3 Key Developments
11.7.3 Cannacare Docs
11.7.3.1 Company Overview
11.8 Application (Apps) Companies
11.8.1 Mass Roots
11.8.1.1 Company Overview
11.8.2 Eaze
11.8.2.1 Company Overview
11.8.2.2 Key Developments
11.8.3 Weedmaps
11.8.3.1 Company Overview
11.8.4 Meadow
11.8.4.1 Company Overview
11.8.4.2 Key Developments
11.8.5 Nestdrop
11.8.5.1 Company Overview
11.8.5.2 Key Developments
11.8.6 Leafly
11.8.6.1 Company Overview
11.8.7 Grassp
11.8.7.1 Company Overview
11.8.8 Dave
11.8.8.1 Company Overview
11.8.9 Frweed Pro
11.8.9.1 Company Overview

List Of Tables
Table 1 Timeline Of Medical Marijuana Legalization
Table 2 The Cannabis Ecosystem In North America Revenue Split ($Billion), 2015-202
Table 3 Full Legalization Of Marijuana Across The U.S. And Associated Tax Revenue Estimate
Table 4 Comparison Of Growing Marijuana In Soil-Based And Soil-Less Medium
Table 5 Cannabis Sativa Vs Cannabis Indica
Table 6 North America Cannabis Derivative Market Value ($Million), 2015-2020
Table 7 North America Marijuana Market Value($Million), By Application, 2015-2020
Table 8 North America Marijuana Market Value ($Million), By Distribution Mode, 2015-2020
Table 9 North America Marijuana Market Value ($Million), By Geography, 2015-2020
Table 10 North America Industrial Hemp Market Value ($Million), By Application, 2015-2020
Table 11 North America Industrial Hemp Market Value ($Million), By Distribution mode, 2015-2020
Table 12 North America Industrial Hemp Market Value ($ Million), By Geography, 2015-2020
Table 13 North America Cannabis Application Market Value ($Million), 2015-2020
Table 14 Diseases & Cure By Cannabis
Table 15 Information About Key Medicinal Marijuana Drugs In North America
Table 16 North America Medical Marijuana Market Value ($Million), By Distribution Mode, 2015-2020
Table 17 North America Medical Marijuana Market Value ($Million), By Geography, 2015-2020
Table 18 North America Recreational Marijuana Market Value ($Million), By Geography, 2015-2020
Table 19 North America Industrial Hemp Food And Baby Care Products Market Value ($Million), By Geography, 2015-2020
Table 20 North America Industrial Hemp Clothing And Textiles Market Value ($Million), By Geography, 2015-2020
Table 21 North America Industrial Hemp Other Application Market Value ($Million), By Geography, 2015-2020
Table 22 North America Cannabis Market By Region ($ Million), 2015-2020
Table 23 The U.S Cannabis Market Value ($Million), By Derivative, 2015-2020
Table 24 The U.S. Cannabis Market Value ($Million), By Application, 2015-2020
Table 25 The U.S. Marijuana Market Value ($Million), By Key States, 2015-2020
Table 26 Marijuana Legalization Details By States
Table 27 Marijuana Posession Details
Table 28 Industrial Hemp Posession Details
Table 29 Canada Cannabis Market Value ($Million), By Derivative, 2015-2020
Table 30 Canada Cannabis Market Value ($Million), By Application, 2015-2020

List Of Figures
Figure 1 Bis Research Methodology
Figure 2 The Europe E-Liquid Market-Research Methodology
Figure 3 Cannabis Comparison By Derivative ($Million) 2015-202
Figure 4 Cannabis Comparison By Application ($ Million) 2014-202
Figure 5 Cannabis Comparison By Geography ($ Million) 2014-202
Figure 6 The Cannabis Ecosystem With Key Players
Figure 7 An Optimistic Estimate For U.S. Marijuana Market (2014)
Figure 8 Key Mergers & Acquisitions (2013-15)
Figure 9 Key Partnerships & Collaborations (2013-15)
Figure 10 Key Product Launches (2013-15)
Figure 11 Key Business Expansion Activities (2013-15)
Figure 12 Key Product Testing Activities (2013-15)
Figure 13 Other Key Developments (2013-15)
Figure 14 Benefits Of Using Cannabis Vending Machines
Figure 15 Why Cannabis Industry Needs Standards
Figure 16 North America Cannabis Industry Analysis-Porter’s Five Forces
Figure 17 North America Cannabis Market Value Chain Analysis
Figure 18 Feature Of Mmpr
Figure 19 Mission Of Crcr
Figure 20 Mission Of Norml
Figure 21 Proposed Best Practices For Regulation Of Cannabis Growing By Ahpa
Figure 22 Arcpc Mission
Figure 23 Hia Mission
Figure 24 Dpa Mission
Figure 25 Steps Taken By Iacm In The Cannabis Industry
Figure 26 Key Features Of Ncia
Figure 27 Cmcia Mission
Figure 28 Naihc Mission
Figure 29 Key Varieties Of Cannabis Strains
Figure 30 The Psychoactive Effects Of Marijuana
Figure 31 Medical Benefits Of Marijuana
Figure 32 Industries Benefiting From Industrial Hemp
Figure 33 Applications Of Cannabis Plant
Figure 34 North America Medical Marijuana Market Value ($Million) Vs Y-O-Y, 2015-2020
Figure 35 North America Recreational Marijuana Market Value ($Million) Vs Y-O-Y, 2015-2020
Figure 36 Applications Of Industrial Hemp
Figure 37 North America Industrial Hemp Food And Baby Care Products Market Value ($Million) Vs Y-O-Y, 2015-2020
Figure 38 Northamerica Industrial Hemp Clothing And Textiles Market Value ($Million) Vs Y-O-Y, 2015-2020
Figure 39 North America Industrial Hemp Other Applications Market Value ($Million) Vs Y-O-Y, 2015-2020
Figure 40 Legalization Status Of Cannabis
Figure 41 Canadian Cannabis Corporation Overall Financials, 2012-2014 ($Million)
Figure 42 Plandai Biotech Overall Financials, 2012-15 ($ Million)
Figure 43 Tweed Marijuana Overall Financials, 2013-15 ($ Million)
Figure 44 Affinor Growers Overall Financials, 2012-14 ($ Million)
Figure 45 Cannabis Sativa Overall Financials, 2012-14 ($ Million)
Figure 46 Cannavest Overall Financials, 2012-14 ($ Million)
Figure 47 Arena Pharmaceuticals Overall Financials, 2012-14 ($Million)
Figure 48 Cannabis Science, Inc. Overall Financials, 2012-14 ($Million)
Figure 49 Gw Pharmaceuticals; Overall Financials 2012-14 ($Million)
Figure 50 Revenue By Segment 2012-14
Figure 51 Revenue By Region 2012-2014
Figure 52 Hemp Inc. Overall Financials, 2012-15 ($ Million)
Figure 53 Insys Therapeutics Overall Financials, 2012-14 ($ Million)
Figure 54 Medical Marijuana Inc. Overall Financials, 2012-14 ($Million)
Figure 55 22nd Century Group Overall Financials, 2012-14 ($ Million)
Figure 56 Otsuka Overall Financials, 2012-2014 ($ Million)
Figure 57 Sanofipharma Overall Financials, 2012-14 ($ Million)
Figure 58 Endexx Corporation Overall Financials, 2012-2014 ($Million)
Figure 59 Green Technology Solutions; Overall Financials, 2012-2015 ($ Million)
Figure 60 Advanced Cannabis Solutions Overall Financials, 2013-2014 ($ Million)
Figure 61 Medbox Overall Financials, 2012-2014 ($ Million)
Figure 62 Surna Inc. Overall Financials, 2012-2014 ($Million)
Figure 63 Cannagrow Overall Financials, 2012-14 ($Million)
Figure 64 Abattis Bioceuticals Overall Financials 2013-14 ($Million)
Figure 65 Cannabis Therapy Corp. Overall Financials, 2014-15 ($Million)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • 22nd Century Group, Inc.
  • Cannabis Sativa Inc.
  • Dave
  • Grassp
  • Leafly
  • Medical Marijuana Inc.
  • MORE
Multi-faced applications of Cannabis have gained attention of many pharmaceutical and research companies in the regions of North America. This has contributed to the increasing applications of cannabis, be it recreational, medicinal or commercial.

Owing to the changing dynamics in the regulatory framework for the Cannabis Industry in North America, the author has published the “North American Cannabis Market – Analysis and Forecast Through 2015–2025” estimating the cannabis derivative market value to grow over $20.7 billion by 2020 at an estimated CAGR of 29.80% from 2014 to 2020.

The report is a compilation of different peripherals of North American Cannabis Market including market divisions by product derivatives-marijuana, hemp and others, its applications- medicinal, recreational & commercial and by regions- the U.S. and Canada.
Herein the revenue generated from each segment, application and region of North America is tracked to compute the market size.

The report also includes porter’s five forces analysis, value chain analysis, market dynamics, key consortium, compliance and regulatory bodies surrounding the North American cannabis market. Due to the diverse ecosystem of this market, a separate section has been incorporated in the report for the key strategies and development activities undertaken by the key market players including producers, pharmaceutical companies, dispensaries, and technology providers among others. The key players are also profiled in detail.

The analyst believes that California and Colorado is dominating whole of the North American Cannabis Market capturing market of $1.2 billion and $0.6 billion respectively due to increasing medicinal applications i.e. estimated to reach $11.6 billion by 2020 with a double digit CAGR. Market players from a host of industry verticals have been aggressively putting in efforts to gain significant market shares, while the market is largely in its nascent stage. While pharmaceutical companies are becoming the major beneficiaries of this market, software and infrastructure providers are also increasing their market share in the cannabis ecosystem. The future growth of the cannabis market is largely reliant on the legalization of recreational or adult use of marijuana which is expected to gain a market share of almost 30% by 2020.

Note: Product cover images may vary from those shown
5 of 6
- 22nd Century Group, Inc.
- Abattis Bioceuticals Corporation
- Advanced Cannabis Solutions
- Affinor Growers
- Agrisoft Development Group
- Arena Pharmaceuticals, Inc.
- Canadian Cannabis Corporation
- Canna Brands Inc.
- Canna Grow Holdings
- Cannabics Pharmaceuticals Inc.
- Cannabis Sativa Inc.
- Cannabis Science, Inc.
- Cannabis Therapy Corporation
- Cannacare Docs
- Cannavest
- Dave
- Eaze
- Endexx Corporation
- Frweed Pro
- Grassp
- Green Technology Solutions Inc. (Gtso)
- Gw Pharmaceuticals
- Hemp, Inc.
- Insys Therapeutics
- Leafly
- Mass Roots
- Meadow
- Medbox, Inc.
- Medical Marijuana Inc.
- Nestdrop
- Omnicanna Health Solutions
- Otsuka Pharmaceutical Co. Ltd
- Plandai Biotechnology
- Privateer Holdings, Inc.
- Quantum 9
- Sanofi Pharmaceuticals
- Surna, Inc.
- Tweed Marijuana Inc.
- Weedmaps

Note: Product cover images may vary from those shown
6 of 6
Question Does this report give an overview of international trade of medicinal marijuana between the United States and Canada?
Answer Yes, this report does contain this information.
Note: Product cover images may vary from those shown
Adroll
adroll